Journal of Enzyme Inhibition and Medicinal Chemistry · 2019 · 21 citations · 33 references
Life SciencesBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryEnzymologyCatalytic MechanismsEnzyme FunctionEnzyme InhibitionEnzyme KineticsEnzyme TargetsEnzyme-substrate RecognitionBacterial Peptidoglycan SynthesisEnzymesEscherichia ColiKinase InhibitorsLigase InhibitorsNovel Antibacterial Drug DiscoveryPeptidoglycan BiosynthesisSteady-state Kinetics
The Mur ligases form a series of consecutive enzymes that participate in the intracellular steps of bacterial peptidoglycan biosynthesis. They therefore represent interesting targets for antibacterial drug discovery. MurC, D, E and F are all ATP-dependent ligases. Accordingly, with the aim being to find multiple inhibitors of these enzymes, we screened a collection of ATP-competitive kinase inhibitors, on Escherichia coli MurC, D and F, and identified five promising scaffolds that inhibited at least two of these ligases. Compounds 1, 2, 4 and 5 are multiple inhibitors of the whole MurC to MurF cascade that act in the micromolar range (IC50, 32–368 µM). NMR-assisted binding studies and steady-state kinetics studies performed on aza-stilbene derivative 1 showed, surprisingly, that it acts as a competitive inhibitor of MurD activity towards D-glutamic acid, and additionally, that its binding to the D-glutamic acid binding site is independent of the enzyme closure promoted by ATP.
33
Anna Gaulton, Anne Hersey, Michał Nowotka et al. · Nucleic Acids Research · 2016 · 2.4K citations · Full text
An improved assay for nanomole amounts of inorganic phosphate
Peter A. Lanzetta, Lawrence J. Alvarez, Peter S. Reinach et al. · Analytical Biochemistry · 1979 · 2.2K citations
Comprehensive characterization of the Published Kinase Inhibitor Set
Jonathan M. Elkins, Vita Fedele, M. Szklarz et al. · Nature Biotechnology · 2015 · 350 citations